Literature DB >> 8341986

Hp and pH: implications for the eradication of Helicobacter pylori.

R H Hunt1.   

Abstract

Helicobacter pylori infection causes inflammation of the gastric and duodenal mucosae, which results in a disturbance of the regulatory mechanisms for gastrin, gastric acid and pepsin secretion. Acid secretion may be decreased, normal or increased, depending on the stage of infection, although the meal-stimulated gastrin response is invariably elevated. The exact mechanisms involved are not known but may be due to the release of cytokines in response to bacterial toxins. H. pylori colonization is reduced by effective acid suppression with proton pump inhibitors, although it is not eradicated. In combination with amoxycillin, omeprazole, up to 40 mg twice daily, eradicated the organism in up to 82% of cases. This synergistic effect may be due to a direct effect of omeprazole on the organism, the protection of amoxycillin from acid degradation, or enhancement of host defence mechanisms accompanying acid suppression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341986     DOI: 10.3109/00365529309098335

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  9 in total

1.  Pretreatment with urea-hydrochloric acid enhances the isolation of Helicobacter pylori from contaminated specimens.

Authors:  Q Song; G W Zirnstein; B Swaminathan; B D Gold
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

3.  One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.

Authors:  C L Perng; J G Kim; H M El-Zimaity; M S Osato; D Y Graham
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

4.  Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Authors:  T Jaworski; I Sarosiek; S Sostarich; K Roeser; M Connor; S Brotze; G Wallner; J Sarosiek
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

5.  In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions.

Authors:  J E Sjöström; J Fryklund; T Kühler; H Larsson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.

Authors:  H Rosengren; R J Polson
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

7.  Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells.

Authors:  W A Belli; J Fryklund
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

8.  Current status of acid pump antagonists (reversible PPIs).

Authors:  W Wurst; M Hartmann
Journal:  Yale J Biol Med       Date:  1996 May-Jun

9.  Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury.

Authors:  Cesar J Garcia; Juan Castro-Combs; Ajoy Dias; Rodrigo Alfaro; Javier Vasallo; Marek Majewski; Tom Jaworski; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Clin Transl Gastroenterol       Date:  2013-07-25       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.